# Clinical Trial Imaging Endpoint Process Standards Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/clinical-trial-imaging-endpoint-process-standards-guidance-for-industry/910804b6-9e1d-47f8-8105-89b586c9622b

> FDA guidance document: Clinical Trial Imaging Endpoint Process Standards Guidance for Industry. Issue date: April 27, 2018. Get complete insights and analysis.

---

## Details

- Title: Clinical Trial Imaging Endpoint Process Standards Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-04-27
- Last Changed: 2020-05-12
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2011-D-0586">FDA-2011-D-0586</a>

## Related Documents

- [Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/atopic-dermatitis-timing-of-pediatric-studies-during-development-of-systemic-drugs/287c413c-cc5e-49ee-af83-9d7183bc4f4d)
- [Pediatric HIV Infection: Drug Development for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-hiv-infection-drug-development-for-treatment/2fd110e1-e45d-44ba-8efb-87a9ba7b8d23)
- [Cancer Clinical Trial Eligibility Criteria: Brain Metastases](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-brain-metastases/18dfb9e1-7a58-4743-8321-ecddace907a4)